IBD patients may stay healthier when doctors monitor medications before they lose efficacy

(Beth Israel Deaconess Medical Center) Proactive monitoring of blood levels of the therapeutic drug infliximab was associated with improved outcomes including lower risk of surgery and hospitalization.